Calyxt Announces New Technology Framework Agreement with Plant Bioscience Limited to Expand IP Portfolio
ST. PAUL, Minn.–(BUSINESS WIRE)–Calyxt,
Inc., a Minnesota-based company developing healthier food products
to benefit both consumers and growers, announced today that the Company
has signed a technology framework agreement with Plant Bioscience
Limited (PBL) to expand Calyxt’s intellectual property (IP) portfolio to
include new product-based IP from leading academic institutions around
the world. Under the new agreement, PBL will offer newly developed
technologies to Calyxt for evaluation and possible acquisition.
Calyxt previously announced licensing agreements with PBL that boosted
the trait development pipeline at the Company, including those for a
resistance trait for powdery mildew – a devastating disease in wheat, as
well as for rice and corn – developed through gene editing by the
Institute of Genetics and Developmental Biology (IGDB, Beijing). This
new collaboration brings PBL’s expertise and network as part of an
overall strategy to expand Calyxt’s existing trait portfolio and will
expedite Calyxt’s ability to grow its crop development pipeline.
“Our continued partnership with PBL is crucial for expanding our product
development pipeline strategy and trait portfolio,” said Calyxt’s CEO
Federico Tripodi. “As a consumer- and product-focused company, Calyxt’s
ability to license traits that are developed by world-class academic
institutions will ensure that Calyxt is ahead of the curve in developing
the healthiest and most sustainable food products, with traits that
consumers all over the world desire.”
“Each day, new and exciting breakthroughs in agricultural science and
research are taking place around the world,” added Dr. Jan Chojecki,
PBL’s Managing Director. “We are pleased to continue and expand upon our
partnership with Calyxt to enable the traits and technologies that are
being developed to create healthier food products that benefit both
consumers and farmers as they continue down the path to market.”
About Calyxt
Calyxt,
Inc. is a fast-growing, consumer-oriented ag company that utilizes
its innovative, patented TALEN® technology to usher in
a new era of agriculture and develop crop products with healthier
characteristics for consumers – all the while helping farmers and food
and agriculture industries reduce their environmental footprints in the
context of climate change. Calyxt believes that agricultural
technologies can have a profound, positive impact on humanity and is
looking to engage those who share this passion for food and agriculture.
Calyxt is located in Minneapolis-St. Paul, Minn., and is a wholly owned
subsidiary of Cellectis.
For further information please visit our website: www.calyxt.com
Calyxt™
and the corporate logo are trademarks owned by Calyxt, Inc.
Talking about gene editing? We do it.
TALEN® is a
registered trademark owned by the Cellectis Group.
About PBL
PBL (Norwich, UK) invests in and promotes innovative technologies from
public and private sources worldwide and is owned jointly by the John
Innes Centre, The Sainsbury
Laboratory, and the BBSRC (Biotechnology
and Biological Sciences Research Council). www.pbltechnology.com
Contacts
For Calyxt
Media:
Jennifer Moore, 917-580-1088
VP
Communications
media@calyxt.com
or
Caitlin
Kasunich / Nick Opich
KCSA Strategic Communications
212-896-1241
/ 212-896-1206
ckasunich@kcsa.com
/ nopich@kcsa.com
or
Investor
Relations:
Simon Harnest, 646-385-9008
VP Corporate
Strategy and Finance
simon.harnest@cellectis.com
